CCK(B) receptors in the periaqueductal grey are involved in electroacupuncture antinociception in the rat cold water tail-flick test (Q47675383)

4 February 2018

title

CCK(B) receptors in the periaqueductal grey are involved in electroacupuncture antinociception in the rat cold water tail-flick test (English)

1 reference

4 February 2018

author name string

Chen XH

series ordinal

1

1 reference

4 February 2018

Geller EB

series ordinal

2

1 reference

4 February 2018

Adler MW

series ordinal

3

1 reference

4 February 2018

publication date

1 June 1998

1 reference

4 February 2018

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

1 reference

4 February 2018

volume

37

1 reference

4 February 2018

issue

6

1 reference

4 February 2018

page(s)

751-757

1 reference

4 February 2018

Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

All three types of opioid receptors in the spinal cord are important for 2/15 Hz electroacupuncture analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Analgesia induced by electroacupuncture of different frequencies is mediated by different types of opioid receptors: another cross-tolerance study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Reversal of tolerance to morphine but no potentiation of morphine-induced analgesia by antiserum against cholecystokinin octapeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Classification and function of CCK receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Interaction of cholecystokinin and somatostatin with a selective mu-opioid agonist and mu- and kappa-antagonists in thermoregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substrates?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Cholecystokinin octapeptide (CCK-8): antagonism to electroacupuncture analgesia and a possible role in electroacupuncture tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Two brain cholecystokinin receptors: implications for behavioral actions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Rat cold water tail-flick: a novel analgesic test that distinguishes opioid agonists from mixed agonist-antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Naloxone blockade of acupuncture analgesia: Endorphin implicated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Two populations of cells that express preprocholecystokinin mRNA in ventral periaqueductal grey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

New peptide in the vertebrate CNS reacting with antigastrin antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Cholecystokinin octapeptide antagonized opioid analgesia mediated by mu- and kappa- but not delta-receptors in the spinal cord of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Cholecystokinin antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

Increased release of immunoreactive CCK-8 by electroacupuncture and enhancement of electroacupuncture analgesia by CCK-B antagonist in rat spinal cord.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900028-8

10.1016/S0028-3908(98)00028-8

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

9707289

1 reference

4 February 2018